A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
NCT01485367
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Senile Purpura
Interventions
DRUG:
adapalene gel 0.3%
Sponsor
Multispecialty Aesthetic Clinical Research Organization
Collaborators
[object Object]